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tion. However, the ability to regenerate is lost when neonatal 
mice are seven days old (10). 
After ischaemic myocardial infarction, 1-day-old neonatal 
mice show myocardial necrosis and systolic dysfunction. How-
ever, when miRNA-15 was inhibited, the heart regenerated 
completely by 21 days through the proliferation of pre-existing 
cardiomyocytes. Micro-RNA-15 plays a significant role by in-
hibiting postnatal cardiomyocyte proliferation. Hence, inhibit-
ing miRNA-15 from the postnatal age to adulthood promotes 
cardiomyocyte proliferation and improves cardiac function af-
ter myocardial infarction. These observations show that regen-
eration mechanisms can be re-awakened in mammals (11, 12). 
Micro-RNA-590 and miRNA-199a initiate the cell cycle re-entry 
and the proliferation of cardiomyocytes in neonatal and adult 
animals. In mice, both miRNA-590 and miRNA-199a promoted 
cardiac regeneration and a significant improvement of cardiac 
functional parameters (13).
In lower vertebrates, such as zebrafish, the heart regenerates 
completely by 4–6 weeks post-injury as a result of an endog-
enous activation of the regeneration process and cardiomyocyte 
de-differentiation and the proliferation of pre-existing cardio-
myocytes (14–16). Epicardium-derived cells undergo epithe-
lial-mesenchymal transition to form coronary smooth muscle 
cells and fibroblasts (15, 17). Epicardial markers, such as tbx18, 
tcf21 and raldh2, are re-expressed after cryoinjury, suggesting 
that the epicardium is crucial for heart regeneration in zebrafish 
(15, 17). Tissue injury reactivates developmental genes in ze-
brafish: this is the basis for complete regeneration without scar 
formation (17).
The Let-7 family of miRNAs is expressed during embryonic 
development (18). Let-7c is upregulated in human cardiac matu-
ration in vitro. Overexpression of the Let-7 family of miRNAs ma-
tures human embryonic stem-cell-derived cardiomyocytes and 
increases cell size, sarcomere length and contraction (1, 19). Let-
7 miRNAs are upregulated in murine and human heart disease 
samples (20). Inhibition of Let-7c improves cardiac remodelling 
and function after infarction in zebrafish and mice (18, 21, 22). In 
zebrafish, the inhibition of Let-7c increases the rate of fibrinoly-
sis, the number of proliferating cell nuclear antigen (PCNA) –pos-
itive cardiomyocytes at 7 dpi, and the expression of the epicardial 
marker raldh2 at 7 dpi. Cardiac function measured with echocar-
diography recovered slightly more rapidly after the inhibition of 
Let-7c. These results reveal a beneficial role of Let-7c inhibition 
in adult zebrafish heart regeneration (22).
Suneeta Narumanchi
MSc, PhD Student, Unit of Cardiovascular Research, Minerva Foundation Institute for Medical Research, 
Biomedicum Helsinki 2U
 
Micro-RNAs in cardiac regeneration 
Introduction
Micro-RNAs (miRNAs) are short, noncoding RNA molecules 
that act as negative regulators of gene expression by inhibiting 
protein translation. Through mRNA, miRNAs regulate signalling 
pathways and affect cell–cell communication (2, 3, 4). Micro-
RNAs control the expression of several genes and influence the 
function of other miRNAs. Micro-RNAs regulate embryogenesis, 
cell proliferation and apoptosis. Recent studies have revealed 
important roles for miRNAs in diseases of adult tissues in mam-
mals, including humans, especially in cancer and cardiovascu-
lar diseases (4). 
Micro-RNAs control cardiomyocyte growth, contractility 
and angiogenesis through cardiomyocytes, endothelial cells, 
smooth muscle cells and fibroblasts. The study of miRNAs thus 
plays an important role in the pathophysiology of cardiovascu-
lar disorders, such as heart failure, myocardial infarction, hyper-
trophy, fibrosis, arrhythmia and atherosclerosis. The regulation 
of miRNAs possibly protects against ischaemia/reperfusion (I/R) 
injury and heart failure (4, 5). Altered miRNA expression could 
be seen in samples of cardiovascular disease patients, and miR-
NAs could thereby be sensitive biomarkers for acute myocardial 
infarction and other cardiac diseases (5).
miRNAs in regeneration
The adult mammalian heart shows a regenerative response upon 
injury; however, it is insufficient to completely heal the heart 
(6–9). A robust regeneration mechanism has been observed in 
neonatal mice. Hearts of 1-day-old neonatal mice regenerate af-
ter partial surgical resection by means of a proliferation of pre-
existing cardiomyocytes. No scar formation or hypertrophy was 
observed, and echocardiography revealed normal systolic func-
Abstract
Heart diseases are the leading cause of death in the de-
veloped world. Novel therapies are required for improv-
ing cardiac remodelling and function after injury, since 
adult mammalian hearts do not completely regenerate 
after injury, either due to an evolutionary loss of or in-
activated regeneration mechanism (1). 
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Micro-RNA-99/100 is highly expressed in an uninjured ze-
brafish heart and downregulated after injury. Fntβ and Smarca5, 
required for zebrafish heart development and regeneration, are 
upregulated as a result of lowered expression of miRNA-99/100. 
A similar pattern is observed in higher mammals. However, 
mammals fail to downregulate miRNA-99/100 after injury (1). 
In a murine model, the blocking of both miRNA-99/100 and 
Let-7c resulted in efficient cardiomyocyte de-differentiation and 
regeneration. Both miRNA-99/100 and Let-7c were blocked by 
anti-mirs. The blocking of both miRNA-99/100 and Let-7c also 
resulted in improved cardiac function (1).
In zebrafish, miRNA-144 is upregulated until 21 days after 
injury, indicating that it could play an important role in the re-
generation process (23). MicroRNA-19 is downregulated during 
zebrafish heart regeneration (24). MicroRNA-101a expression is 
depleted three days after amputation (dpa) in adult zebrafish. 
However, it is again upregulated by 7–14 dpa, until regener-
ation is completed. Upregulation of miRNA-101a is essential 
for cardiomyocyte proliferation and scar clearance in adult ze-
brafish (24).
Micro-RNA-133 is required for cardiac development, and 
the expression of miRNA-133 is reduced during regeneration. 
The depletion of miRNA-133 increased cardiomyocyte prolif-
eration and reduced scar formation in adult zebrafish (25). Ge-
netic knockout of miRNA-133 elevated cardiomyocyte prolifer-
ation in neonatal mice (26). In adult mice, it has been observed 
that miRNA-133 levels decrease during cardiac hypertrophy, 
while an elevation of miRNA-133 inhibits hypertrophy (26).
Conclusions
MiRNAs are fascinating candidates for studying cardiac regen-
eration. They regulate cardiac development, contractility, func-
tion and regeneration after myocardial infarction or ischaemic 
injury (12). Several miRNAs are regulated after cardiac injury. 
Here, the focus has been on miRNA-15, miRNA-199a, miR-
NA-590, miRNA-101a, Let-7c, miRNA-99/100, miRNA-144, 
miRNA-19, and miRNA-133, as well as their role in cardiac re-
generation after infarction in adult zebrafish, neonatal mice and 
adult mice. Regulating miRNAs has potential effects on cardio-
myocyte proliferation and regeneration, hence making miRNAs 
probable targets for improving the regenerative capacity of the 
injured mammalian heart.
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